Zevra Therapeutics, Inc.

8-K Shareholder vote results Jun 5, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Entered a material agreement; Terminated a material agreement; Regulation FD disclosure Mar 16, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Results of operations (earnings release); Director or officer change Mar 9, 2026 8-K Director or officer change Dec 17, 2025 8-K Director or officer change; Regulation FD disclosure Dec 2, 2025 8-K Director or officer change; Regulation FD disclosure Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Shareholder vote results May 29, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 8-K Completed an acquisition or disposition; Results of operations (earnings release); Other events Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 12, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Entered a material agreement; Regulation FD disclosure Feb 27, 2025 8-K Director or officer change; Regulation FD disclosure Dec 6, 2024 8-K Regulation FD disclosure; Other events Nov 22, 2024 10-Q Quarter ended 2024-09-30 Nov 13, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Sep 20, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Other events Aug 9, 2024 8-K Results of operations (earnings release) Aug 8, 2024 8-K Regulation FD disclosure; Other events Aug 5, 2024 8-K Entered a material agreement; Terminated a material agreement Jul 12, 2024 8-K Regulation FD disclosure; Other events Jul 9, 2024 8-K Regulation FD disclosure; Other events Jun 3, 2024 8-K Shareholder vote results May 13, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 8, 2024 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Regulation FD disclosure Apr 10, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 8-K Results of operations (earnings release); Previously issued financials not reliable Mar 28, 2024 8-K Regulation FD disclosure; Other events Mar 27, 2024